CONSENT TO SUBLEASEConsent to Sublease • July 27th, 2016 • CRISPR Therapeutics AG • Biological products, (no disgnostic substances)
THIS CONSENT TO SUBLEASE (this “Consent”), dated as of May 16, 2016, is entered into by and among MIT 650 MAIN STREET LLC, a Massachusetts limited liability company (“Prime Landlord”), PFIZER INC., a Delaware corporation (“Sublandlord”) and CRISPR THERAPEUTICS, INC., a Delaware corporation (“Subtenant”).
